Showing 611-620 of 834 results for "".
- Heidelberg Engineering Presents Xtreme Research Awardhttps://modernod.com/news/heidelberg-engineering-presents-xtreme-research-award/2482287/Highlighting the work of outstanding researchers in ophthalmic imaging, the 14th annual Heidelberg Engineering Xtreme Research Award has been presented to Christian Burri, PhD, Biomedical Engineering, optoLab Institute for Human Centered Engineering, Bern University of Applied Sciences, and
- New Research Reveals COVID-19 Virus Could Damage Visionhttps://modernod.com/news/new-research-reveals-covid-19-virus-could-damage-vision/2482285/Researchers at the University of Missouri School of Medicine have discovered the virus that causes COVID-19 can breach the blood-retinal barrier with potential long-term consequences in the eye. Using a humanized ACE2 mice model, research led by Pawan Kumar Singh, PhD, an assi
- Prevent Blindness Announces Recipients of the 2024 Jenny Pomeroy Award and the Rising Visionary Awardhttps://modernod.com/news/prevent-blindness-announces-recipients-of-the-2024-jenny-pomeroy-award-and-the-rising-visionary-award/2482251/Prevent Blindness named Mission for Vision (MFV) the recipient of the 2024 Jenny Pomeroy Award for Excellence in Vision and Public Health; and Erica Shelton, OD, MS, FAAO, Clinical Instructor and PhD Candidate, The Ohio State University College of Optometry, has been named as the r
- Opthea Announces Changes to Executive Leadershiphttps://modernod.com/news/opthea-appoints-us-based-leadership-with-fred-guerard-as-ceo-and-peter-lang-as-cfo/2481918/Opthea announced that the company’s Chief Executive Officer, Megan Baldwin, PhD, will transition to Founder and Chief Innovation Officer, effective today. The company says the move is reflective of the company’s strategy to advance its US and global presence and commercialization
- Glaucoma Treatment Research at Missouri S&T Receives NIH Fundinghttps://modernod.com/news/glaucoma-treatment-research-at-missouri-st-receives-nih-funding/2481759/The Missouri University of Science and Technology (S&T) announced that the National Institutes for Health (NIH) has awarded an R01 grant to Professor Hu Yang, PhD, who is S&T’s Doshi Endowed Department Chair of Chemical and Biochemical Engineering. The grant will prov
- Viridian Appoints Scott Myers as President and Chief Executive Officerhttps://modernod.com/news/viridian-appoints-scott-myers-as-president-and-chief-executive-officer/2481388/Viridian Therapeutics has appointed Scott Myers as President and Chief Executive Officer, as well as a member of the Board of Directors, effective February 6, 2023. He succeeds Jonathan Violin, PhD, who has led Viridian since its inception in 2020. “Our progres
- Viatris Closes Acquisitions of Oyster Point Pharma and Famy Life Sciences, Establishing New Eye Care Divisionhttps://modernod.com/news/viatris-closes-acquisitions-of-oyster-point-pharma-and-famy-life-sciences-establishing-new-viatris-eye-care-division-1/2481326/Viatris announced that it has closed its acquisitions of Oyster Point Pharma and Famy Life Sciences to establish a new Viatris Eye Care Division. The transaction was first announced on November 7. Former Oyster Point Pharma CEO, Jeffrey Nau, PhD, MMS, will lead the new di
- Tarsus Announces Transition Plans for Board of Directorshttps://modernod.com/news/tarsus-announces-transition-plans-for-board-of-directors/2481168/Tarsus Pharmaceuticals announced several expected upcoming transitions to its Board of Directors by year-end. Tarsus Co-Founder and Chairman, Michael Ackermann, PhD, plans to transition off the Board of Directors. Upon Dr. Ackermann’s planned transition, Wendy Yarno, industry veteran and cu
- Pixium Vision Announces Participation in Upcoming Scientific Conferences in September 2022https://modernod.com/news/pixium-vision-announces-participation-in-upcoming-scientific-conferences-in-september-2022/2481049/Pixium Vision announced that senior management will participate in the following scientific conferences during September 2022: 22nd EURETINA Congress, September 1-4, Hamburg & Virtual Lloyd Diamond, CEO; Ralf Hornig, PhD, and director of clinic
- Foundation Fighting Blindness Announces Leadership Changeshttps://modernod.com/news/foundation-fighting-blindness-announces-leadership-changes/2480924/The Foundation Fighting Blindness announced the promotions of Jason Menzo to chief executive officer of the Foundation, and Russell Kelley, PhD, MBA, to managing director of the Retinal Degeneration (RD) Fund, the venture arm of the Foundation, effective Ju